Posted on: in News

Ilika are pleased to announce that they now have access to their Stereax laboratories based at the University of Southampton, which re-opened this week. With many employees working remotely during the COVID-19 pandemic, business momentum continued for Stereax miniature solid-state batteries. We liaised with our Stereax customers about measures we were taking and possible impact on delivery and are pleased to confirm there were no order cancellations so our FY21 expectations have not been affected.

The move to implementing a manufacturing strategy for Stereax has begun, using some of the recently over-subscribed £14.2m investment. Production of these miniature solid-state batteries will be done by a third-party fabrication facility (FAB) and responses to Requests for Information from four FABs in Europe and North America have already been received.

All of this is part of Ilika’s strategic change to move to a manufacturing company of our pioneering solid-state battery technology for tomorrow’s MedTech and Industry 4.0 devices. In a connected world where one size does not fit all, the fact that these microbatteries are customisable address key challenges of powering things from smart contact lenses to industrial condition monitoring equipment. Ilika is working with an ecosystem of OEMs who have differing ranges of power requirements. If you’d like to discuss your requirements and find out more about how our prototype batteries can help, contact us now at info@ilika.com